Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Human immunodeficiency virus 1 Pol polyprotein is a polyprotein precursor encoded by the pol gene of HIV-1. It is proteolytically processed to yield three essential viral enzymes: protease (PR), reverse transcriptase (RT), and integrase (IN). Each enzyme is crucial for distinct steps in the HIV replication cycle—PR is responsible for viral protein processing and maturation, RT for synthesizing DNA from the viral RNA genome, and IN for integrating the viral DNA into the host chromosome[1][2][3][4][5]. The polyprotein forms through ribosomal frameshifting as a Gag-Pol fusion, and its correct maturation is required for the production of infectious virus particles. The structure and activity of Pol and its constituent enzymes are the primary targets of current antiretroviral therapies, with inhibitors developed to target each of the mature enzymes[3][4]. The polyprotein’s mutation-prone loci are important markers for monitoring antiretroviral therapy resistance and guiding patient management.
Inhibition of polyprotein-encoded enzymatic activities: - Blocking HIV-1 protease impairs virus maturation and infectivity - Blocking reverse transcriptase halts conversion of viral RNA to DNA, inhibiting replication - Blocking integrase prevents integration of viral DNA into the host genome
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human immunodeficiency virus 1 Pol polyprotein (HIV-1 Pol).